[EN] INDOLYLALKYLAMINO-METHYLIDENECARBAMATE DERIVATIVES USEFUL AS GNRH ANTAGONISTS<br/>[FR] DERIVES D'INDOLYLALKYLAMINO-METHYLIDENECARBAMATE UTILES EN TANT QU'ANTAGONISTES DE GNRH
申请人:ASTRAZENECA AB
公开号:WO2004018420A1
公开(公告)日:2004-03-04
The invention relates to a group of novel indole compounds of Formula (I): wherein: R1, R2, R4, R6, R6a, R7, R8, R9, R10, and A are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
[EN] PYRROLE DERIVATIVES AS GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONISTS<br/>[FR] DERIVES DE PYRROLE UTILISES EN TANT QU'ANTAGONISTES DE L'HORMONE LIBERANT DE LA GONADOTROPHINE (GNRH)
申请人:ASTRAZENECA AB
公开号:WO2005079805A1
公开(公告)日:2005-09-01
The invention relates to a group of novel thieno-pyrrole compounds of formula (I) wherein: R1, R2, R3, R4 M, and R5 are as defined in the specification, as inter alia, gonadotrophin releasing hormone antagonists. Novel compounds of formula (I) are also claimed. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
[EN] THIENO-PYRROLE COMPOUNDS AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE<br/>[FR] COMPOSES DE THIENO-PYRROLE UTILISES COMME ANTAGONISTES DE L'HORMONE DE LIBERATION DE GONADOTROPHINE
申请人:ASTRAZENECA AB
公开号:WO2004018479A1
公开(公告)日:2004-03-04
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I), wherein: R1, R2, R4, R5, R6, R6a, R7, R8, A and B are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
Compounds of formula (I):
1
wherein B, X, R
3
, R
21
, R
22
, R
1
and R
c
are defined herein. The compounds are useful as inhibitors of HCV NS3 protease.